New Roads Open Up for Implementing Immunotherapy in Mesothelioma, Clinical and Developmental Immunology, vol.180, issue.3, p.927240, 2012. ,
DOI : 10.4049/jimmunol.0803826
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm, Nature Immunology, vol.313, issue.10, pp.889-896, 2010. ,
DOI : 10.1016/j.ccr.2009.06.017
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes, Trends in Immunology, vol.23, issue.11, pp.549-555, 2002. ,
DOI : 10.1016/S1471-4906(02)02302-5
Alternative Activation of Macrophages: An Immunologic Functional Perspective, Annual Review of Immunology, vol.27, issue.1, pp.451-483, 2009. ,
DOI : 10.1146/annurev.immunol.021908.132532
Anti-tumour strategies aiming to target tumour-associated macrophages, Immunology, vol.331, issue.Suppl 1, pp.93-104, 2013. ,
DOI : 10.1111/imm.12023
Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma, Cancer, vol.205, issue.14 suppl, pp.5234-5244, 2011. ,
DOI : 10.1002/cncr.26143
Ratio of Intratumoral Macrophage Phenotypes Is a Prognostic Factor in Epithelioid Malignant Pleural Mesothelioma, PLoS ONE, vol.44, issue.9, p.106742, 2014. ,
DOI : 10.1371/journal.pone.0106742.t002
Intratumoral macrophage phenotype and CD8+ T lymphocytes as potential tools to predict local tumor outgrowth at the intervention site in malignant pleural mesothelioma, Lung Cancer, vol.88, issue.3, pp.332-337, 2015. ,
DOI : 10.1016/j.lungcan.2015.03.013
CCL2 (monocyte chemoattractant protein-1) and cancer, Seminars in Cancer Biology, vol.14, issue.3, pp.149-154, 2004. ,
DOI : 10.1016/j.semcancer.2003.10.009
Inflammatory chemokines and metastasis???tracing the accessory, Oncogene, vol.11, issue.25, pp.3217-3224, 2014. ,
DOI : 10.1016/j.yexcr.2010.12.021
Identification of Novel Markers for the Diagnosis of Malignant Pleural Mesothelioma, The American Journal of Pathology, vol.178, issue.3, pp.1033-1042, 2011. ,
DOI : 10.1016/j.ajpath.2010.12.014
CCL2, Galectin-3, and SMRP Combination Improves the Diagnosis of Mesothelioma in Pleural Effusions, Journal of Thoracic Oncology, vol.7, issue.5, pp.883-889, 2012. ,
DOI : 10.1097/JTO.0b013e31824c9272
Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy, European Journal of Cancer, vol.42, issue.6, pp.717-727, 2006. ,
DOI : 10.1016/j.ejca.2006.01.003
Autocrine CSF-1R signaling drives mesothelioma chemoresistance via AKT activation, Cell Death and Disease, vol.17, issue.4, p.1167, 2014. ,
DOI : 10.1128/MCB.20.4.1436-1447.2000
Phase II Study of Dasatinib in Patients with Previously Treated Malignant Mesothelioma (Cancer and Leukemia Group B 30601): A Brief Report, Journal of Thoracic Oncology, vol.7, issue.4, pp.755-759, 2012. ,
DOI : 10.1097/JTO.0b013e318248242c
Serum level of macrophage colony-stimulating factor is increased in prostate cancer patients with bone metastasis, Human Cell, vol.60, issue.1, pp.1-6, 2008. ,
DOI : 10.1111/j.1749-0774.2007.00042.x
Pretreatment Serum Levels of Cytokines and Cytokine Receptors in Patients with Non-Small Cell Lung Cancer, and Correlations with Clinicopathological Features and Prognosis, Oncology, vol.70, issue.2, pp.115-125, 2006. ,
DOI : 10.1159/000093002
Serum macrophage colony-stimulating factor (M-CSF) in patients with Hodgkin lymphoma, Medical Oncology, vol.206, issue.3, pp.2143-2147, 2012. ,
DOI : 10.1007/s12032-011-0010-1
Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis, Clinica Chimica Acta, vol.380, issue.1-2, pp.208-212, 2007. ,
DOI : 10.1016/j.cca.2007.02.037
Defining GM-CSF- and Macrophage-CSF-Dependent Macrophage Responses by In Vitro Models, The Journal of Immunology, vol.188, issue.11, pp.5752-5765, 2012. ,
DOI : 10.4049/jimmunol.1103426
Macrophage polarization in tumour progression, Seminars in Cancer Biology, vol.18, issue.5, pp.349-355, 2008. ,
DOI : 10.1016/j.semcancer.2008.03.004
Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells, Cancer Res, vol.57, pp.4849-4854, 1997. ,
Impact of tumor-derived CCL2 on T cell effector function, Immunology Letters, vol.91, issue.2-3, pp.239-245, 2004. ,
DOI : 10.1016/j.imlet.2003.12.009
CCL2 Blockade Augments Cancer Immunotherapy, Cancer Research, vol.70, issue.1, pp.109-118, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-2326
Cells, American Journal of Respiratory Cell and Molecular Biology, vol.44, issue.2, pp.230-237, 2011. ,
DOI : 10.1165/rcmb.2010-0080OC
Genetic and Pharmacological Targeting of CSF-1/CSF-1R Inhibits Tumor-Associated Macrophages and Impairs BRAF-Induced Thyroid Cancer Progression, PLoS ONE, vol.18, issue.1, p.54302, 2013. ,
DOI : 10.1371/journal.pone.0054302.s006
The Sympathetic Nervous System Induces a Metastatic Switch in Primary Breast Cancer, Cancer Research, vol.70, issue.18, pp.7042-7052, 2010. ,
DOI : 10.1158/0008-5472.CAN-10-0522
Macrophages mediate gemcitabine resistance of pancreatic adenocarcinoma by upregulating cytidine deaminase, Oncogene, vol.46, issue.29, pp.3812-3819, 2014. ,
DOI : 10.1038/nature11249